UBS has given British American Tobacco (BAT) a "Neutral" rating and a target price of 2800 pence after the company's recent capital markets day.
Analyst Faham Baig mentioned that BAT has confirmed its medium-term financial targets, indicating progress and confidence in meeting its commitments.
The assessment reflects UBS's cautious optimism about BAT's future performance, as the company continues to navigate the changing tobacco industry landscape and focuses on achieving its strategic objectives.